Immunitybio Inc IBRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:51 PM EDT
5.29quote price arrow up+0.02 (+0.38%)
Volume
36,308
Close
5.27quote price arrow up+0.36 (+7.33%)
Volume
4,504,455
52 week range
1.25 - 6.93
Loading...
  • Open4.91
  • Day High5.30
  • Day Low4.82
  • Prev Close4.91
  • 52 Week High6.93
  • 52 Week High Date05/09/23
  • 52 Week Low1.25
  • 52 Week Low Date10/19/23

Key Stats

  • Market Cap3.552B
  • Shares Out673.95M
  • 10 Day Average Volume3.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change4.98

KEY STATS

  • Open4.91
  • Day High5.30
  • Day Low4.82
  • Prev Close4.91
  • 52 Week High6.93
  • 52 Week High Date05/09/23
  • 52 Week Low1.25
  • 52 Week Low Date10/19/23
  • Market Cap3.552B
  • Shares Out673.95M
  • 10 Day Average Volume3.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change4.98

RATIOS/PROFITABILITY

  • EPS (TTM)-1.13
  • P/E (TTM)-4.68
  • Fwd P/E (NTM)-7.75
  • EBITDA (TTM)-341.764M
  • ROE (TTM)-3,787.09%
  • Revenue (TTM)621,999.979
  • Gross Margin (TTM)-
  • Net Margin (TTM)-93,866.88%
  • Debt To Equity (MRQ)-142.84%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immunitybio Inc

Profile

MORE
Immunitybio, Inc. is a vertically integrated, clinical-stage biotechnology company developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Using its proprietary platforms that amplify both the innate and adaptive branches of the immune system, its advances therapies and vaccines to defeat urologic and other cancers, as well as infectious diseases. Its platforms and their associated product candidates are designed to...
Patrick Soon-Shiong M.D.
Executive Chairman of the Board, Global Chief Scientific and Medical Officer
Richard Adcock
President, Chief Executive Officer, Director
Lennie Sender
Chief Operating Officer
David Sachs
Chief Financial Officer
Enrique Dilone Ph.D.
Chief Technology Officer
Address
3530 JOHN HOPKINS COURT
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
IOVA
Iovance Biotherapeutics Inc
11.31-0.41-3.50%
CRNX
Crinetics Pharmaceuticals Inc
42.97-0.04-0.09%
SWTX
SpringWorks Therapeutics Inc
40.10-2.37-5.58%
XENE
Xenon Pharmaceuticals Inc
39.88-0.43-1.07%
IDYA
IDEAYA Biosciences Inc
37.13-0.49-1.30%